Medicare Part D coverage · azelaic acid · RxCUI 1659803

azelaic acid 150 MG/ML Topical Foam [Finacea]

Per the CMS 2026 Part D formulary file, azelaic acid 150 MG/ML Topical Foam [Finacea] is covered by 349 Medicare Part D plans (6.9% of enrollable products), averaging Tier 3.6, with prior authorization required on 0% of covering formularies.

6.9%
Plan coverage
349
Plans covering
T3.6
Avg tier
0%
Prior auth required

Verify with CMS →

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.

What the CMS Formulary Data Shows for azelaic acid 150 MG/ML Topical Foam [Finacea]

Per the CMS 2026 Part D formulary file, azelaic acid 150 MG/ML Topical Foam [Finacea] (RxNorm concept RXCUI 1659803, generic name azelaic acid) appears on 62 distinct formulary files spanning 349 Medicare Part D plan offerings - 6.9% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.6.

Real-world access to azelaic acid 150 MG/ML Topical Foam [Finacea] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 1.6% require step therapy. 32.3% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 37,203 Part D beneficiaries filled azelaic acid 150 MG/ML Topical Foam [Finacea] in 2023, with total plan-and-beneficiary spending of $9,731,946 and an average per-beneficiary annual cost of $261.59. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry azelaic acid 150 MG/ML Topical Foam [Finacea] today.

Coverage Details

Formularies covering
62
Plans covering
349
Coverage rate
6.9%
Tier range
Tier 1 – Tier 4
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
0% of formularies
Step therapy required
1.6% of formularies
Quantity limits
32.3% of formularies

2023 Medicare Spending

Beneficiaries
37,203
Total spending
$9,731,946
Avg per beneficiary
$261.59

Tier Distribution Across Plans

24 plans
Tier 1, Preferred Generic
55 plans
Tier 3, Preferred Brand
21 plans
Tier 4, Non-Preferred

Medicare Advantage Plans (MA-PD) Covering azelaic acid 150 MG/ML Topical Foam [Finacea]

100 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Gold Coast Health Plan Total Care Advantage (HMO D-SNP) Ventura County Medi-Cal Managed Care Commission T1 No $0 CA
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) Health Care Service Corporation T1 No $0 NM
Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) Health Care Service Corporation T1 No $0 NM
Horizon NJ TotalCare (HMO D-SNP) Horizon Healthcare OF NEW Jersey, Inc. T1 No $0 NJ
SecureBlue (HMO D-SNP) HMO Minnesota T1 No $0 MN
Hamaspik Medicare Choice (HMO D-SNP) Hamaspik, Inc. T1 No $0 NY
Provider Partners Pennsylvania Community Plan (HMO I-SNP) Provider Partners Health Plan OF Pennsylvania, Inc T1 No $0 PA
Provider Partners North Carolina Community Plan (HMO I-SNP) Provider Partners Health Plan OF North Carolina T1 No $0 NC
Provider Partners Indiana Community Plan (HMO I-SNP) Provider Partners Health Plan OF Indiana T1 No $0 IN
Provider Partners Missouri Community Plan (HMO I-SNP) Provider Partners Health Plan OF Missouri, Inc. T1 No $0 MO
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) Hcsc Insurance Services Company T1 No $4.80 TX
Provider Partners Texas Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF Texas, Inc. T1 No $4.80 TX
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) GHS Insurance Company T1 No $5.00 OK
Provider Partners Illinois Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF Illinois T1 No $15.20 IL
Provider Partners Pennsylvania Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF Pennsylvania, Inc T1 No $32.70 PA
Provider Partners Pennsylvania Essential Plan (HMO I-SNP) Provider Partners Health Plan OF Pennsylvania, Inc T1 No $32.70 PA
Hamaspik Medicare Select (HMO D-SNP) Hamaspik, Inc. T1 No $34.50 NY
Provider Partners North Carolina Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF North Carolina T1 No $36.20 NC
Provider Partners North Carolina Essential Plan (HMO I-SNP) Provider Partners Health Plan OF North Carolina T1 No $36.20 NC
Provider Partners Indiana Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF Indiana T1 No $38.40 IN
Show the next 30 plans
Provider Partners Indiana Essential Plan (HMO I-SNP) Provider Partners Health Plan OF Indiana T1 No $38.40 IN
Provider Partners Kentucky Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF Kentucky T1 No $38.40 KY
Provider Partners Missouri Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF Missouri, Inc. T1 No $43.00 MO
Provider Partners Missouri Essential Plan (HMO I-SNP) Provider Partners Health Plan OF Missouri, Inc. T1 No $43.00 MO
eternalHealth Forever (HMO) Eternalhealth, Inc. T3 No $0 MA
eternalHealth Freedom (PPO) Eternalhealth, Inc. T3 No $0 MA
eternalHealth Give Back (PPO) Eternalhealth, Inc. T3 No $0 MA
eternalHealth Horizon (HMO) Eternalhealth OF Arizona Inc T3 No $0 AZ
eternalHealth Grand Give Back (HMO) Eternalhealth OF Arizona Inc T3 No $0 AZ
eternalHealth + Fry's Medicare Advantage (HMO) Eternalhealth OF Arizona Inc T3 No $0 AZ
Senior Care Plus Essential plan (HMO) Hometown Health Plan, Inc. T3 No $0 NV
Senior Care Plus Complete Plan (HMO) Hometown Health Plan, Inc. T3 No $0 NV
Renown Preferred Plan by Senior Care Plus (HMO) Hometown Health Plan, Inc. T3 No $0 NV
Senior Care Plus Extensive Duals Plan (HMO D-SNP) Hometown Health Plan, Inc. T3 No $0 NV
Senior Care Plus Enriched Duals Plan (HMO D-SNP) Hometown Health Plan, Inc. T3 No $0 NV
MyAdvocate Medicare Advantage SILVER (HMO-POS) Beshp, Inc. T3 No $0 NE
Great Plain Medicare Advantage Gold (HMO I-SNP) Sanford Health Plan T3 No $0 IA, SD
Align ChoicePlus (PPO) Sanford Health Plan OF Minnesota T3 No $0 MN
Great Plains Medicare Advantage Gold (HMO I-SNP) Good Samaritan Insurance Plan OF Nebraska, Inc. T3 No $0 NE
Align ChoicePlus (PPO) Sanford Health Plan T3 No $0 IA, SD
Align ChoicePlus (PPO) Sanford Health Plan T3 No $0 ND
Great Plains Medicare Advantage Gold (HMO I-SNP) Sanford Health Plan T3 No $0 ND
Align Dual Partnership (HMO D-SNP) Sanford Health Plan T3 No $0 ND
Ally Rx (HMO D-SNP) Security Health Plan OF Wisconsin, Inc. T3 No $0 WI
Esteem Rx (HMO-POS) Security Health Plan OF Wisconsin, Inc. T3 No $0 WI
Blue Best Life Classic (HMO) Medisun, Inc. T3 No $0 AZ
Blue Best Life Classic (HMO) Medisun, Inc. T3 No $0 AZ
HealthTeam Advantage Plan I (PPO) Care N' Care Insurance Company OF North Carolina T3 No $0 NC
HealthTeam Advantage Vitality Plan (PPO) Care N' Care Insurance Company OF North Carolina T3 No $0 NC
HealthTeam Advantage Diabetes & Heart Care (HMO C-SNP) Care N' Care Insurance Company OF North Carolina T3 No $0 NC

Showing top 50 of 100 plans.

Frequently Asked Questions

Is azelaic acid 150 MG/ML Topical Foam [Finacea] covered by Medicare Part D?

Yes, azelaic acid 150 MG/ML Topical Foam [Finacea] is covered by 349 Medicare Part D plans (6.9% of all Part D formularies).

What tier is azelaic acid 150 MG/ML Topical Foam [Finacea] on Medicare Part D plans?

azelaic acid 150 MG/ML Topical Foam [Finacea] averages Tier 3.6 across Part D plans, ranging from Tier 1 to Tier 4.

Does azelaic acid 150 MG/ML Topical Foam [Finacea] require prior authorization?

0% of Part D formularies require prior authorization for azelaic acid 150 MG/ML Topical Foam [Finacea]. Step therapy: 1.6%. Quantity limits: 32.3%.

How much does Medicare spend on azelaic acid 150 MG/ML Topical Foam [Finacea]?

In 2023, total Medicare Part D spending on azelaic acid 150 MG/ML Topical Foam [Finacea] was $9,731,946, covering 37,203 beneficiaries. The average spend per beneficiary was $261.59.

Nationwide similar Part D drugs

Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare